Characterization of the role of IS256 in the development of intermediate vancomycin resistance in a clinical Staphylococcus aureus isolate

被引：0
|
作者：
Nagel, M. [1 ]
Jansen, A. [1 ]
Tuerck, M. [1 ]
Bierbaum, G. [1 ]
机构：
[1] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-5300 Bonn, Germany
来源：
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY | 2007年 / 297卷
关键词：
D O I：
暂无
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：65 / 66
页数：2
相关论文
共 50 条
  • [21] Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
    Hafer, Cory
    Lin, Ying
    Kornblum, John
    Lowy, Franklin D.
    Uhlemann, Anne-Catrin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5845 - 5851
  • [22] Vancomycin Resistance in Staphylococcus aureus
    McGuinness, Will A.
    Malachowa, Natalia
    DeLeo, Frank R.
    YALE JOURNAL OF BIOLOGY AND MEDICINE, 2017, 90 (02): : 269 - 281
  • [23] Intermediate vancomycin resistance in Staphylococcus aureus:: a major threat or a minor inconvenience?
    Johnson, AP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (03) : 289 - 291
  • [24] Study on the virulome and resistome of a vancomycin intermediate-resistance Staphylococcus aureus
    Fu, Jie
    Wang, Kan
    Ye, Congxiu
    Chen, Ling
    Liang, Yi
    Mao, Yuzhu
    Chen, Jinxuan
    Peng, Ruixin
    Chen, Yanni
    Shi, Fan
    Huang, Teng-Yi
    Liu, Junyan
    MICROBIAL PATHOGENESIS, 2020, 145
  • [25] Activated ADI pathway: the initiator of intermediate vancomycin resistance in Staphylococcus aureus
    Tan, Xin-Ee
    Neoh, Hui-min
    Looi, Mee-Lee
    Chin, Siok Fong
    Cui, Longzhu
    Hiramatsu, Keiichi
    Hussin, Salasawati
    Jamal, Rahman
    CANADIAN JOURNAL OF MICROBIOLOGY, 2017, 63 (03) : 260 - 264
  • [26] Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S-aureus-type resistance to vancomycin
    McAleese, F
    Wu, SW
    Sieradzki, K
    Dunman, P
    Murphy, E
    Projan, S
    Tomasz, A
    JOURNAL OF BACTERIOLOGY, 2006, 188 (03) : 1120 - 1133
  • [27] Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
    Howden, Benjamin P.
    Davies, John K.
    Johnson, Paul D. R.
    Stinear, Timothy P.
    Grayson, M. Lindsay
    CLINICAL MICROBIOLOGY REVIEWS, 2010, 23 (01) : 99 - +
  • [28] Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure
    Gaillard, Tiphaine
    Dupieux-Chabert, Celine
    Butin, Marine
    Dumitrescu, Oana
    Naceur, Oilida
    Bouveyron, Caroline
    Martra, Annie
    Bes, Michele
    Tristan, Anne
    Vandenesch, Francois
    Lina, Gerard
    Laurent, Frederic
    Rasigade, Jean-Philippe
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (04) : 1032 - 1035
  • [29] Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
    Cui, LZ
    Tominaga, E
    Neoh, HM
    Hiramatsu, K
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) : 1079 - 1082
  • [30] Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
    Cui, Longzhu
    Neoh, Hui-min
    Shoji, Mitsutaka
    Hiramatsu, Keiichi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1231 - 1234
12345